Thu, Dec 18, 2014, 7:53 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • muppettfodder muppettfodder Dec 15, 2012 9:55 PM Flag

    What is essentially happening, poorly guided funds sold, funds who understand biotech and drugs, bought

    retail was driven out long ago and the news was not a beacon to retail, to come in. This was and is, institutional play.

    Long ago, when genetic and oligo antisense began development, large pharma took notice and got involved. There is no denying this fact.

    Now, today, you have a transcript to review and I suggest you look long and hard at it. For those who sold on Friday, and prior, I suggest, there is more reason now for the stock to go back to $ 15. Just my opinion, however, the biggest fear is "does it work" and the way the partners have spoken, its very clear, they are very convinced this version of antisense makes a very, very big difference. Take special note to the part of the transcript where they discuss moving out from the hyper-indication to more common indications in millions of obese individuals.

    I wonder to myself, are there forces at play here, to scare away retail from buying and holding long? Could be. The funds want it all to themselves, and large pharma wants and needs to have a piece, to have CONTROL. Think.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
59.55+2.07(+3.60%)Dec 18 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Oracle Corporation
NYSEThu, Dec 18, 2014 4:00 PM EST
Pier 1 Imports, Inc.
NYSEThu, Dec 18, 2014 4:02 PM EST